Drug
Dexmethylphenidate clinical trials
Also written Focalin®.
- studies test it
- 15
- open now
- 0
- in phase 3
- 4
- first study started
- 2002
How studies write it
Studies that test it under each name
Brand
Combined with it in one product
Studies by the year they started
15 studies that test it; most in 2006 (4)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 6
- Phase 2
- 3
- Phase 3
- 4
- Phase 4
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 4
Cingulate Therapeutics (3) · Novartis (3) · Teva Pharmaceuticals USA (2) · Novartis Pharmaceuticals (2) · NYU Langone Health (1) · Seattle Children's Hospital (1) · Massachusetts General Hospital (1) · University of Cincinnati (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses dexmethylphenidate is read from its arms, and is right about nine times in ten.
Testing it · 15
- In-clinic Crossover Study in Subjects With Two Treatments (Fed vs Fasted)CompletedPhase 1Cingulate TherapeuticsNCT07119073Written as Dexmethylphenidate
- Duration and Efficacy of Azstarys on Adult ADHD Symptoms and Executive Function in Early EveningCompletedPhase 4NYU Langone HealthNCT06000501Written as Serdexmethylphenidate/dexmethylphenidate
- Dexmethylphenidate Hydrochloride Tablets Under Non-Fasting ConditionsCompletedPhase 1Teva Pharmaceuticals USANCT00829673Written as Dexmethylphenidate Hydrochloride
- Dexmethylphenidate Hydrochloride Tablets Under Fasting ConditionsCompletedPhase 1Teva Pharmaceuticals USANCT00829712Written as Dexmethylphenidate Hydrochloride
- Fed-Fast Crossover Study to Assess the Effect of Food With CTx-1301 in Healthy SubjectsCompletedPhase 1Cingulate TherapeuticsNCT04449250Written as Dexmethylphenidate
- CTx-1301 Comparative Bioavailability StudyCompletedPhase 1/2Cingulate TherapeuticsNCT04138498Written as Dexmethylphenidate 5 Mg Oral Capsule, Extended Release
- Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XRCompletedPhase 3Seattle Children's HospitalNCT00393042Written as Dexmethylphenidate
- Study of Dopamine Transporter Receptor Occupancy With Long-acting Dex-methylphenidateCompletedPhase 1/2Massachusetts General HospitalNCT00593138Written as dex-methylphenidate
- A Study of Dex-methylphenidate Extended Release in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedPhase 4Novartis PharmaceuticalsNCT00564954Written as Dex-methylphenidate hydrochloride extended-release (Focalin XR)
- Efficacy and Safety of Dex-Methylphenidate Extended Release 30 mg Versus 20 mg in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting.CompletedPhase 4Novartis PharmaceuticalsNCT00776009Written as Dex-Methylphenidate hydrochloride Extended Release (Focalin® XR)
- Use of Focalin for Fatigue in SarcoidosisCompletedPhase 4University of CincinnatiNCT00361387Written as d-methylphenidate
- Safety and Efficacy Study of Dexmethylphenidate in Children With ADHDCompletedPhase 3NovartisNCT00141063Written as Focalin XR
- Safety and Efficacy Study of Dexmethylphenidate in Children With ADHDCompletedPhase 3NovartisNCT00141050Written as Focalin XR
- Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity DisorderCompletedPhase 3NovartisNCT00301236Written as Dexmethylphenidate HCl extended-release capsules
- D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer PatientsCompletedPhase 2Celgene CorporationNCT00047476Written as dexmethylphenidate(d-mph)
Codes
What other systems call dexmethylphenidate · ClinicalTrials.gg INT008971
- MeSH (NLM) D064699Dexmethylphenidate HydrochlorideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) M32RH9MFGPDEXMETHYLPHENIDATEConfirmed FDA, NLM, Wikidata
- RxNorm 352372Confirmed FDA, Wikidata
- Wikidata Q1207210dexmethylphenidateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C26642DexmethylphenidateOne source FDA
- DrugBank DB06701One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D064699 | Dexmethylphenidate Hydrochloride | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | M32RH9MFGP | DEXMETHYLPHENIDATE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 352372 | — | Confirmed FDA, Wikidata |
| Wikidata | Q1207210 | dexmethylphenidate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C26642 | Dexmethylphenidate | One source FDA |
| DrugBank | DB06701 | — | One source Wikidata |
Also registered as dexmethylphenidate hydrochloride (UNII 1678OK0E08 · RxNorm 353105).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.